We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ML
10726
CALL
DELISTED
MoneyLion Inc.
ML
$178K ﹤0.01%
4,483
+60
+1% +$3.19K
BELFB
10727
CALL
Bel Fuse Inc Class B
BELFB
$4.19B
$177K ﹤0.01%
11,400
-600
-5% -$9.77K
DOUG icon
10728
CALL
Douglas Elliman
DOUG
$185M
$177K ﹤0.01%
38,850
-2,048
-5% -$11.3K
SCS
10729
CALL
DELISTED
Steelcase
SCS
$177K ﹤0.01%
16,500
-1,600
-9% -$18.5K
SDIG
10730
PUT
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$177K ﹤0.01%
10,660
-6,670
-38% -$212K
ABUS icon
10731
PUT
Arbutus Biopharma
ABUS
$924M
$176K ﹤0.01%
64,800
-117,500
-64% -$301K
BUR icon
10732
PUT
Burford Capital
BUR
$960M
$176K ﹤0.01%
17,400
-4,600
-21% -$40.4K
GPGI
10733
GPGI Inc
GPGI
$3.7B
$176K ﹤0.01%
+40,646
New +$230K
DADA
10734
PUT
DELISTED
Dada Nexus
DADA
$176K ﹤0.01%
21,700
+2,400
+12% +$18.4K
SIRI icon
10735
SiriusXM
SIRI
$9.59B
$176K ﹤0.01%
2,866
-102,883
-97% -$6.39M
WGS icon
10736
GeneDx Holdings
WGS
$2.33B
$176K ﹤0.01%
4,241
-4,262
-50% -$289K
OLK
10737
CALL
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$176K ﹤0.01%
11,600
-12,100
-51% -$157K
CASA
10738
DELISTED
Casa Systems, Inc. Common Stock
CASA
$176K ﹤0.01%
44,778
-44,884
-50% -$195K
BCYC
10739
PUT
Bicycle Therapeutics
BCYC
$273M
$175K ﹤0.01%
10,400
-900
-8% -$19K
LFCR icon
10740
Lifecore Biomedical
LFCR
$179M
$175K ﹤0.01%
17,539
-28,321
-62% -$280K
TKNO icon
10741
Alpha Teknova
TKNO
$391M
$175K ﹤0.01%
20,758
-8,583
-29% -$90.5K
YMM icon
10742
CALL
Full Truck Alliance
YMM
$9.14B
$175K ﹤0.01%
19,300
-2,100
-10% -$14.3K
JWSM.U
10743
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
$175K ﹤0.01%
17,721
-1,242
-7% -$12.3K
VLD
10744
DELISTED
Velo3D, Inc.
VLD
$175K ﹤0.01%
3,623
-2,673
-42% -$313K
PAYA
10745
CALL
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$175K ﹤0.01%
26,700
+2,100
+9% +$11.8K
CPSS icon
10746
CALL
Consumer Portfolio Services
CPSS
$205M
$174K ﹤0.01%
+17,000
New +$207K
LDI icon
10747
loanDepot
LDI
$303M
$174K ﹤0.01%
121,042
-5,577
-4% -$15.1K
LTH icon
10748
CALL
Life Time Group Holdings
LTH
$10.1B
$173K ﹤0.01%
+13,400
New +$191K
SRT
10749
DELISTED
Startek Inc.
SRT
$173K ﹤0.01%
+59,693
New +$221K
PBR icon
10750
Petrobras
PBR
$115B
$172K ﹤0.01%
14,757
-4,414,756
-100% -$61.1M

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.